Probucol for type 2 diabetes mellitus - Wikidata - awgldk - TriplyDB

Probucol for type 2 diabetes mellitus

Probucol for type 2 diabetes mellitus

http://www.wikidata.org/entity/Q24195163

about

Probucol for type 2 diabetes mellitus

http://www.wikidata.org/entity/Q24195163

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Probucol for type 2 diabetes mellitus

@ast

Probucol for type 2 diabetes mellitus

@en

Probucol for type 2 diabetes mellitus

@en-gb

Probucol for type 2 diabetes mellitus

@nl

type

label

Probucol for type 2 diabetes mellitus

@ast

Probucol for type 2 diabetes mellitus

@en

Probucol for type 2 diabetes mellitus

@en-gb

Probucol for type 2 diabetes mellitus

@nl

prefLabel

Probucol for type 2 diabetes mellitus

@ast

Probucol for type 2 diabetes mellitus

@en

Probucol for type 2 diabetes mellitus

@en-gb

Probucol for type 2 diabetes mellitus

@nl

P1433

Q24195163-64D04D6A-C545-4594-9C2C-844932A806D8

P1476

Q24195163-EC0B2365-5DF5-457F-94D3-CC59E407A61A

P2093

Q24195163-417CB1C5-CEC4-42F9-A841-21A7BDF88692

Q24195163-41F4AF5A-00BE-4CEF-B10C-09AB150B806A

Q24195163-68C3D8AD-B603-49AB-8FB2-31EEA29F7CF2

Q24195163-95F0111C-36B2-47EB-A968-135B9EAA1A1F

Q24195163-BE33E49A-1EB3-4CFB-8DFF-3534F30416B7

P2860

Q24195163-0A488515-BBC9-4C4F-8675-B620EC35BBFF

Q24195163-1098157C-5669-4BAE-9810-966776210760

Q24195163-147EF201-A472-4639-99D1-2C78920A4044

Q24195163-18DC3B3D-7A4A-4873-97F6-0DCE2CA48CC0

Q24195163-3026296F-3359-405E-A999-41E8063C3AFB

Q24195163-30767A3B-761E-41FE-889A-65E509AA8003

Q24195163-3533C32C-9F8E-490E-9EF6-2C8ABD0600EB

Q24195163-3C346555-2641-4286-9C14-F840D51635BD

Q24195163-423E53A2-A44B-4B72-89C2-10E1FE9F6859

Q24195163-52BD0D41-0019-4D5C-8006-4E5A02939407

P31

Q24195163-09758F2A-86C8-497D-9B70-09845423D559

P356

Q24195163-4F2620E5-DE16-4F91-8C37-5D233D7FBFF6

P577

Q24195163-40A54FF4-1E2A-4CDF-BE67-CF51A74854DD

P921

Q24195163-8C41D290-47B3-4DD5-A2E0-A7AC34260871

P356

14651858.CD007846.PUB2

P1433

Cochrane Database of Systematic Reviews

P1476

Probucol for type 2 diabetes mellitus

@en

P2093

Cheng Cheng Li

http://www.w3.org/2001/XMLSchema#string

Jin Hui Tian

http://www.w3.org/2001/XMLSchema#string

KeHu Yang

http://www.w3.org/2001/XMLSchema#string

Yan Yang

http://www.w3.org/2001/XMLSchema#string

Yong Jian Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmaceutical industry sponsorship and research outcome and quality: systematic review

The case of the misleading funnel plot

Measuring inconsistency in meta-analyses

Quantifying heterogeneity in a meta-analysis

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase.

P31

scholarly article

P356

10.1002/14651858.CD007846.PUB2

http://www.w3.org/2001/XMLSchema#string

P577

2014-07-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P921

type-2 diabetes